SEBI recovers GDR-case penalty from Sterling Biotech's Chetan Sandesara

The Enforcement Action

The Securities and Exchange Board of India (SEBI) has formally closed a long-running recovery in one of India's older market-manipulation matters. In a notice signed at Mumbai on 15 July 2026, SEBI Recovery Officer Pankaj Yuvaraj Shinde recorded the completion of Recovery Certificate No. 6543 of 2023, dated 16 May 2023, drawn against Shri Chetan Sandesara (PAN ANIPS6175K) in the matter of the issue of Global Depository Receipts (GDRs) by Sterling Biotech Ltd.

The recovery certificate had been drawn for a penalty of Rs 23,61,000, together with interest, costs and charges. Per the notice, SEBI has received the entire outstanding dues of Rs 27,12,428 - a sum that includes interest and costs - and the recovery "stands completed" in exercise of powers under Section 28A of the SEBI Act, 1992, read with the relevant provisions of the Income-tax Act, 1961.

The penalty itself was imposed by an adjudicating order dated 8 December 2021 (Order/GR/KG/2021-22/14437-14441) in the Sterling Biotech GDR matter. The recovery notice is an enforcement step rather than a fresh finding: it records that a demand already crystallised through SEBI's adjudication has now been collected in full. There is no public response from Chetan Sandesara to the recovery on the official record.

How the Scheme Worked

The recovery traces back to a SEBI investigation into Sterling Biotech's GDR issue, covering the period 1 September 2003 to 31 October 2003. According to SEBI's adjudication order in the company's matter, Sterling issued 23,28,045 GDRs - amounting to about US$15.37 million - on 1 October 2003, with the receipts listed on the Luxembourg Stock Exchange and the proceeds routed through Banco Efisa.

SEBI observed that a single entity, Fresia Worldwide Limited, subscribed to 96.65% of the issue (22,50,000 GDRs). Per the order, Fresia paid the subscription amount using a loan it obtained, through a credit agreement, from Banco Efisa, S.A. The order records that Mr Nitin Sandesara, then CMD of Sterling, signed an account charge agreement with Banco - in effect, Sterling itself provided the security for the loan that Fresia used to subscribe to Sterling's own GDRs.

That arrangement, SEBI noted, was "an integral part" of the credit agreement, and the order states the GDR issue "would not have been subscribed" had the company not given such security. Meanwhile, the company told the stock exchanges that it had closed the issue of GDRs, which, per the order, made investors believe the issue had been genuinely subscribed.

SEBI's finding was that the combination of the undisclosed security arrangement and the corporate announcement of a successful subscription amounted to misleading disclosure that "induced investors to deal in shares of Sterling". On that basis, the order records, "the scheme of issuance of GDRs was fraudulent". The proceedings against the company itself were later disposed of without penalty, because Sterling had by then been ordered into liquidation by the NCLT, Mumbai Bench; the penalties fell on the individuals named as promoters and directors, including Chetan Sandesara, through the December 2021 order.

The Law Invoked

Per SEBI's orders, the individuals were proceeded against under Section 15HA of the SEBI Act, 1992, which provides for a monetary penalty for fraudulent and unfair trade practices. The charge was framed under Section 12(a), (b) and (c) of the SEBI Act read with Regulations 3(a), (b), (c), (d) and 4(1) of the SEBI (Prohibition of Fraudulent and Unfair Trade Practices Relating to Securities Market) Regulations, 2003 - the PFUTP Regulations. In plain terms, those provisions prohibit deceptive devices, manipulative practices and misleading conduct in dealing with securities.

The recovery itself was effected under Section 28A of the SEBI Act, 1992. That section imports the recovery machinery of the Income-tax Act, 1961, allowing SEBI to recover an unpaid penalty as if it were a tax arrear - through attachment, sale of assets and similar measures - and to issue a recovery certificate to a designated Recovery Officer.

Because the underlying determination is a SEBI adjudication and not a criminal conviction, it is a regulatory finding that is appealable, rather than a verdict of a criminal court.

What Happens Next

The completion of Recovery Certificate No. 6543 of 2023 closes this particular demand. Interest stops running on the sum recovered, and the specific enforcement file relating to it is, in SEBI's words, "completed". It does not by itself extinguish any other demand, certificate or proceeding in the wider Sterling Biotech matter.

An order of a SEBI adjudicating officer can be challenged before the Securities Appellate Tribunal (SAT) within the limitation period, and thereafter, on a question of law, before the Supreme Court. A recovery certificate is not itself an adjudication; it is the enforcement of a demand that has already crystallised after the penalty fell due and remained unpaid.

Where any part of a matter remains under investigation or appeal elsewhere, those steps continue on their own track. As a matter of principle, a SEBI finding is a regulatory conclusion tested through the appellate process, and any person named retains the statutory remedies available to them.

What It Means

For ordinary investors, the Sterling Biotech matter is a textbook illustration of how a GDR issue can be dressed up to look like genuine foreign-investor demand. The mechanism SEBI described - a company quietly securing the loan that funds the overseas subscriber, then announcing a fully subscribed issue - is the pattern regulators have flagged across several GDR cases. The practical lesson is to treat a bare "issue successfully closed" announcement with caution, and to look at who actually subscribed and how the subscription was funded.

The more encouraging signal is enforcement follow-through. A penalty is only as meaningful as the regulator's ability to collect it. Section 28A, which links SEBI to the Income-tax department's recovery powers, is what allows the regulator to pursue a demand years after the original order - here, a penalty imposed in 2021 in a matter dating to 2003 has now been recovered in 2026.

Investors can protect themselves by verifying disclosures at source. Corporate announcements are filed with the BSE and NSE and are public; SEBI orders and recovery actions are published on sebi.gov.in. Checking the primary record, rather than relying on second-hand summaries, remains the single most reliable safeguard.

FAQ

What exactly did SEBI do here?

SEBI's Recovery Officer recorded that Recovery Certificate No. 6543 of 2023, drawn against Chetan Sandesara for a Rs 23,61,000 penalty in the Sterling Biotech GDR matter, has been satisfied in full. SEBI states it received Rs 27,12,428, including interest and costs, and that the recovery "stands completed" under Section 28A of the SEBI Act, 1992.

Does this mean the person named is guilty of a crime?

No. A SEBI adjudication is a regulatory finding, not a criminal conviction, and it is appealable to the Securities Appellate Tribunal. Where any related allegation is at an investigation stage before another agency, it remains an allegation, not a finding of guilt; the person is presumed innocent until proven guilty and due process continues.

What was the scheme SEBI described?

Per SEBI's order, a single entity subscribed to almost all of Sterling Biotech's 2003 GDR issue using a loan that Sterling itself secured through an account charge agreement. The company then announced that the issue had closed. SEBI found this combination misled investors and held the scheme of issuance to be fraudulent.

Can the underlying order still be appealed?

An adjudicating officer's order can be challenged before the Securities Appellate Tribunal within the prescribed period, and on a point of law before the Supreme Court. A recovery certificate, by contrast, enforces a demand that has already crystallised after the penalty fell due and remained unpaid.

How can I check a SEBI order or recovery action myself?

All SEBI adjudication orders and recovery notices are published on sebi.gov.in under the Enforcement section. You can search by the entity's name, the order number or the recovery certificate number. Reading the primary document is the most reliable way to understand what a regulator has actually found or done.

This report is based on the official SEBI notice completing Recovery Certificate No. 6543 of 2023 dated 15 July 2026, read with SEBI's adjudication order in the Sterling Biotech GDR matter, both published by SEBI.